Reciente Producción Científica

1. IL-6, NLR, and SII markers and their relation with alterations in CD8+ T-Lymphocyte subpopulations in patients treated for lung adenocarcinoma. Lorenzo Islas-Vazquez, Dolores Aguilar-Cazares, Miriam Galicia-Velasco, Uriel Rumbo-Nava, Manuel Meneses-Flores, Cesar Luna-Rivero, Jose Sullivan Lopez-Gonzalez Biology (Basel) 2020 Nov; 9(11): 376. doi: 10.3390/biology9110376

3. The double-edge sword of autophagy in cancer: From tumor suppression to pro-tumor activity. Rodolfo Chavez-Dominguez, Mario Perez-Medina, Jose S. Lopez-Gonzalez, Miriam Galicia-Velasco, Dolores Aguilar-Cazares. Front Oncol. 2020; 10: 578418. doi: 10.3389/fonc.2020.578418

4. Dietary compounds as epigenetic modulating agents in cancer. Ángeles Carlos-Reyes, José Sullivan López-González, Manuel Meneses-Flores, Dolores Gallardo-Rincón, Erika Ruíz-García, Laurence A. Marchat, Horacio Astudillo-de la Vega, Olga N. Hernández de la Cruz, César López-Camarillo Front Genet. 2019; 10: 79. doi: 10.3389/fgene.2019.00079

5. Regulation networks driving vasculogenic mimicry in solid tumors. Olga N. Hernández de la Cruz, José Sullivan López-González, Raúl García-Vázquez, Yarely M. Salinas-Vera, Marcos A. Muñiz-Lino, Dolores Aguilar-Cazares, César López-Camarillo, Ángeles Carlos-Reyes. Front Oncol. 2019; 9: 1419. doi: 10.3389/fonc.2019.01419.

6. Contribution of angiogenesis to inflammation and cancer. Dolores Aguilar-Cazares, Rodolfo Chavez-Dominguez, Ángeles Carlos-Reyes, César Lopez-Camarillo, Olga N. Hernadez de la Cruz, Jose S. Lopez-Gonzalez. Front Oncol. 2019; 9: 1399. doi: 10.3389/fonc.2019.01399

7. miR 145 5p is associated with pathological complete response to neoadjuvant chemotherapy and impairs cell proliferation by targeting TGFβR2 in breast cancer. García-García F, Salinas-Vera YM, García-Vázquez R, Marchat LA, Rodríguez-Cuevas S, López-González JS, Carlos-Reyes Á, Ramos-Payán R, Aguilar-Medina M, Pérez-Plasencia C, Ruíz-García E, López-Camarillo C.Oncol Rep. 2019 Jun;41(6):3527-3534. doi: 10.3892/or.2019.7102.

8. MicroRNA-143 is associated With pathological complete response and regulates multiple signaling proteins in breast cancer. García-Vázquez R, Marchat LA, Ruíz-García E, Astudillo-de la Vega H, Meneses-García A, Arce-Salinas C, Bargallo-Rocha E, Carlos-Reyes Á, López-González JS, Pérez-Plasencia C, Ramos-Payán R, Aguilar-Medina M, López-Camarillo C. Technol Cancer Res Treat. 2019 Jan 1; 18:1533033819827309. doi: 10.1177/1533033819827309.

9. Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells. Salinas-Vera YM, Marchat LA, García-Vázquez R, González de la Rosa CH, Castañeda-Saucedo E, Tito NN, Flores CP, Pérez-Plasencia C, Cruz-Colin JL, Carlos-Reyes Á, López-González JS, Álvarez-Sánchez ME, López-Camarillo C. Cancer Lett. 2018 Sep 28;432:17-27. doi: 10.1016/j.canlet.2018.06.003.

10. let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer. García-Vázquez R, Gallardo Rincón D, Ruiz-García E, Meneses García A, Hernández De La Cruz ON, Astudillo-De La Vega H, Isla-Ortiz D, Marchat LA, Salinas-Vera YM, Carlos-Reyes Á, López-González S, Ramos-Payan R, López-Camarillo C. Oncol Rep. 2018 Jun;39(6):3086-3094. doi: 10.3892/or.2018.6366.

11. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth. Maria del Carmen Rodríguez-Salazar, Moises Armides Franco-Molina, Edgar Mendoza-Gamboa, Ana Carolina Martínez-Torres, Pablo Zapata-Benavides, José Sullivan López-González, Erika Evangelina Coronado-Cerda, Juan Manuel Alcocer-González, Reyes Silvestre Tamez-Guerra, Cristina Rodríguez-Padilla. Oncol Lett. 2017 Jul; 14(1): 844–852. doi: 10.3892/ol.2017.6202